The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801FORMAN, Lloyd J.Brain research bulletin. 2003, Vol 61, Num 2, pp 153-158, issn 0361-9230, 6 p.Article

Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiationROELANDT, Truus; HEUGHEBAERT, Carol; BRED, Stephanie et al.Experimental dermatology. 2012, Vol 21, Num 9, pp 688-693, issn 0906-6705, 6 p.Article

Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric arteryHO, W.-S. Vanessa; HILEY, C. Robin.British journal of pharmacology. 2003, Vol 138, Num 7, pp 1320-1332, issn 0007-1188, 13 p.Article

Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT₃ receptor-mediated von Bezold-Jarisch reflexGODLEWSKI, Grzegorz; GÖTHERT, Manfred; MALINOWSKA, Barbara et al.British journal of pharmacology. 2003, Vol 138, Num 5, pp 767-774, issn 0007-1188, 8 p.Article

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptorKLEGERIS, Andis; BISSONNETTE, Christopher J; MCGEER, Patrick L et al.British journal of pharmacology. 2003, Vol 139, Num 4, pp 775-786, issn 0007-1188, 12 p.Article

Cannabinoid system in the skin - a possible target for future therapies in dermatologyKUPCZYK, Piotr; REICH, Adam; SZEPIETOWSKI, Jacek C et al.Experimental dermatology. 2009, Vol 18, Num 8, pp 669-679, issn 0906-6705, 11 p.Article

CB₁ cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction. CommentaryWAGNER, Jens A; KAI HU; KARCHER, Jan et al.British journal of pharmacology. 2003, Vol 138, Num 7, pp 1183-1184, issn 0007-1188, 10 p.Article

A3 adenosine and CB1 receptors activate a PKC-sensitive Cl^- current in human nonpigmented ciliary epithelial cells via a Gβγ-coupled MAPK signaling pathwayCHANJUAN SHI; SZCZESNIAK, Anna; MAO, Lucy et al.British journal of pharmacology. 2003, Vol 139, Num 3, pp 475-486, issn 0007-1188, 12 p.Article

(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity onlyFRIDE, Ester; FEIGIN, Cfir; PONDE, Datta E et al.European journal of pharmacology. 2004, Vol 506, Num 2, pp 179-188, issn 0014-2999, 10 p.Article

Variations in the cannabinoid receptor 1 gene predispose to migraineJUHASZ, Gabriella; LAZARY, Judit; ANDERSON, Ian M et al.Neuroscience letters. 2009, Vol 461, Num 2, pp 116-120, issn 0304-3940, 5 p.Article

Pharmacological actions of cannabinoidsPERTWEE, R. G.Handbook of experimental pharmacology. 2005, Vol 168, pp 1-51, issn 0171-2004, 51 p.Article

Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB₂) in rodents and primatesGONSIOREK, W; LUNN, C. A; FAN, X et al.British journal of pharmacology. 2007, Vol 151, Num 8, pp 1262-1271, issn 0007-1188, 10 p.Article

Desulfohaplosamate, a new phosphate-containing steroid from Dasychalina sp., is a selective cannabinoid CB2 receptor ligandCHIANESE, Giuseppina; FATTORUSSO, Ernesto; TAGLIALATELA-SCAFATI, Orazio et al.Steroids. 2011, Vol 76, Num 10-11, pp 998-1002, issn 0039-128X, 5 p.Article

Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB₁ and CB₂ receptorsGOVAERTS, Sophie J; MUCCIOLI, Giulio G; HERMANS, Emmanuel et al.European journal of pharmacology. 2004, Vol 495, Num 1, pp 43-53, issn 0014-2999, 11 p.Article

The diverse CB₁ and CB₂ receptor pharmacology of three plant cannabinoids : Δ⁹-tetrahydrocannabinol, cannabidiol and Δ⁹-tetrahydrocannabivarinPERTWEE, R. G.British journal of pharmacology. 2008, Vol 153, Num 2, pp 199-215, issn 0007-1188, 17 p.Article

Targeting the cannabinoid CB2 receptor : modelling and structural determinants of CB2 selective ligandsPOSO, A; HUFFMAN, J. W.British journal of pharmacology. 2008, Vol 153, Num 2, pp 335-346, issn 0007-1188, 12 p.Article

No association of CNR1 gene variations with susceptibility to schizophreniaSEIFERT, Jürgen; OSSEGE, Sebastian; EMRICH, Hinderk M et al.Neuroscience letters. 2007, Vol 426, Num 1, pp 29-33, issn 0304-3940, 5 p.Article

5-Sulfonyl-benzimidazoles as selective CB2 agonists-Part 2GIJSEN, Harrie J. M; DE CLEYN, Michel A. J; SURKYN, Michel et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 547-552, issn 0960-894X, 6 p.Article

Neuromorphological background of cannabis addictionWENGER, Tibor; MOLDRICH, Gabriella; FURST, Susanna et al.Brain research bulletin. 2003, Vol 61, Num 2, pp 125-128, issn 0361-9230, 4 p.Article

CB1 AND CB2 CANNABINOID RECEPTOR EXPRESSION DURING DEVELOPMENT AND IN EPILEPTOGENIC DEVELOPMENTAL PATHOLOGIESZUROLO, E; IYER, A. M; SPLIET, W. G. M et al.Neuroscience. 2010, Vol 170, Num 1, pp 28-41, issn 0306-4522, 14 p.Article

Endocannabinoids as positive or négative factors in hematopoietic cell migration and differentiationPATINKIN, Deborah; MILMAN, Garry; BREUER, Aviva et al.European journal of pharmacology. 2008, Vol 595, Num 1-3, pp 1-6, issn 0014-2999, 6 p.Article

Therapeutic potential of cannabinoid receptor ligands : Current statusSINGH, J; BUDHIRAJA, S.Methods and findings in experimental and clinical pharmacology. 2006, Vol 28, Num 3, pp 177-183, issn 0379-0355, 7 p.Article

Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory painGUINDON, Josée; DE LEAN, André; BEAULIEU, Pierre et al.Pain (Amsterdam). 2006, Vol 121, Num 1-2, pp 85-93, issn 0304-3959, 9 p.Article

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. CommentaryHILEY, C. R; KAUP, S. S; STATON, P. C et al.British journal of pharmacology. 2007, Vol 152, Num 5, issn 0007-1188, 559-561, 825-831 [10 p.]Article

Cannabinoid signaling in glial cellsSTELLA, Nephi.Glia (New York, NY. Print). 2004, Vol 48, Num 4, pp 267-277, issn 0894-1491, 11 p.Article